Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • Polyethylenimine Linear (PEI MW 40,000): Precision Transf...

    2025-11-12

    Polyethylenimine Linear (PEI MW 40,000): Precision Transfection for Transient Gene Expression

    Introduction: The Principle Behind Polyethylenimine Linear Transfection

    Effective gene delivery is the linchpin of modern molecular biology, enabling functional genomics, recombinant protein production, and the exploration of complex cellular pathways. Polyethylenimine Linear (PEI, MW 40,000)—a linear polyethylenimine transfection reagent—stands out as a robust DNA transfection reagent for in vitro studies, engineered for high efficiency, serum compatibility, and scalability.

    PEI MW 40,000 operates by condensing negatively charged DNA into positively charged complexes, enhancing their affinity for the negatively charged proteoglycans on cell membranes. This electrostatic matchmaking facilitates endocytosis-mediated DNA uptake, maximizing internalization and subsequent gene expression. With transfection efficiencies often reaching 60–80% in standard cell lines like HEK-293, CHO-K1, and HeLa, PEI MW 40,000 has become the molecular biology transfection reagent of choice for both routine and advanced research applications (Polyethylenimine Linear (PEI MW 40,000): Precision DNA Tr...).

    Experimental Workflow: Step-by-Step Transfection with PEI MW 40,000

    1. Preparation of DNA/PEI Complexes

    • Use PEI MW 40,000 supplied at 2.5 mg/mL (APExBIO, SKU: K1029). Dilute to working concentration using sterile, nuclease-free water or suitable buffer.
    • Mix plasmid DNA (typically 1–2 µg per well in a 6-well plate) with PEI in a defined ratio (commonly 1:2 to 1:3 DNA:PEI mass ratio).
    • Incubate the DNA/PEI mixture for 10–20 minutes at room temperature to allow complex formation.

    2. Cell Seeding and Transfection

    • Seed cells (e.g., HEK-293, HEK293T, CHO-K1, HepG2, or HeLa) to reach 60–80% confluency at the time of transfection.
    • Add the DNA/PEI complexes directly to cells in serum-containing medium—PEI MW 40,000 is a serum-compatible transfection reagent, eliminating the need for medium changes.
    • Incubate for 4–6 hours, then optionally replace with fresh medium to minimize cytotoxicity for sensitive cell types.

    3. Post-Transfection Analysis

    • Protein expression or gene function analysis can typically commence 24–48 hours post-transfection.
    • PEI MW 40,000 supports protocols from small-scale (96-well) to large bioreactor volumes (up to 100 liters), making it ideal for both exploratory and production-scale workflows (Innovations in ...).

    Protocol Enhancements

    • Optimize DNA:PEI ratios for each cell line; for HEK-293 transfection, a 1:2.5 ratio typically yields peak efficiency.
    • Filter-sterilize PEI solutions and use freshly prepared complexes for maximum reproducibility.
    • Store PEI at -20°C for long-term or at 4°C for frequent use to prevent degradation from freeze-thaw cycles.

    Advanced Applications and Comparative Advantages

    Polyethylenimine Linear (PEI MW 40,000) is transformative for both transient gene expression and recombinant protein production. Its ability to deliver plasmid DNA efficiently in serum-containing media, coupled with scalability, sets it apart from cationic lipids and other polymers.

    Transient Gene Expression and Recombinant Protein Production

    PEI MW 40,000 enables rapid, high-yield protein expression in mammalian systems—crucial for applications such as antibody production, viral vector generation, and functional genomics. For example, using HEK-293 or CHO-K1 cells, researchers routinely achieve transfection efficiencies of 70–80% and milligram-level protein yields per liter of culture (see A Precision Tool...). This performance is directly linked to the dense, stable DNA/PEI particles formed, which resist aggregation and maintain functional integrity in complex media.

    Epigenetic and Immunometabolic Research

    Recent advances leverage PEI MW 40,000 for dissecting complex regulatory networks in neuroinflammation and metabolism. For instance, in the landmark study by Li et al. (2025), polyethylenimine-based transfection was pivotal in manipulating NOD2 expression in astrocytes, unraveling how H3K18 lactylation amplifies neuroinflammatory pyroptosis in models of bilirubin encephalopathy. Such work highlights the reagent’s unique value as a molecular biology transfection reagent for both functional gene studies and epigenetic modulation (Epigenetic and ...).

    Comparative Performance Insights

    • Serum Compatibility: Unlike many lipid-based reagents, PEI MW 40,000 maintains high efficiency in the presence of serum, streamlining protocols and reducing cytotoxicity.
    • Scalability: From 96-well screening to 100-liter bioreactors, PEI MW 40,000 delivers consistent performance—a key differentiator for industrial and translational research.
    • Cost Efficiency: PEI is economical for large-scale transient gene expression, lowering per-experiment costs compared to single-use commercial kits.

    For a deeper dive into workflow integration and comparative benchmarks, see Mechanism, Evidence ...—which complements the data-driven focus here by detailing additional performance metrics and use-case scenarios.

    Troubleshooting and Optimization: Practical Tips for Maximum Success

    • Low Transfection Efficiency:
      • Check DNA purity (A260/280 ≥ 1.8), as contaminants can inhibit complexation and uptake.
      • Optimize DNA:PEI ratio for your cell type; some lines require higher PEI for optimal delivery.
      • Ensure cells are healthy and at mid-log phase; over-confluent or stressed cells reduce efficiency.
    • High Cytotoxicity:
      • Reduce the amount of PEI or shorten exposure time; excessive PEI can trigger apoptosis or necrosis.
      • Perform a medium change 4–6 hours post-transfection to remove free complexes.
    • Batch-to-Batch Variability:
      • Use consistent cell passage numbers and freshly prepared PEI solutions.
      • Aliquot PEI stocks to avoid repeated freeze-thaw cycles, which can degrade polymer structure.
    • Large-Scale Challenges:
      • Scale reagent volumes proportionally; maintain optimal mixing for homogeneous complex formation.
      • Pre-test protocols in small-scale bioreactors before full-scale application to identify process bottlenecks.

    Additional troubleshooting strategies and protocol enhancements are provided in Precision DNA Tr..., which extends this discussion with expert tips and real-world case studies.

    Future Outlook: Expanding Horizons in Molecular Biology

    As the boundaries of in vitro gene manipulation continue to expand, Polyethylenimine Linear (PEI MW 40,000) is poised to underpin next-generation research in synthetic biology, gene therapy, and omics-driven diagnostics. Ongoing innovations are integrating PEI-based delivery with CRISPR/Cas systems, advanced nanoparticle platforms, and single-cell transcriptomics, charting new territory for precision medicine and disease modeling.

    Recent studies—such as the work of Li et al. (2025)—underscore the reagent’s critical role in deciphering epigenetic and immunometabolic networks in neural inflammation. The ability to transiently modulate gene expression in primary astrocytes, as demonstrated in their investigation of H3K18 lactylation and NOD2-driven pyroptosis, exemplifies the transformative potential of this technology for neurobiology and beyond.

    For reliable, scalable, and high-efficiency transfection, APExBIO’s Polyethylenimine Linear (PEI, MW 40,000) remains the gold standard, enabling researchers to transition seamlessly from discovery to application. To explore detailed specifications or order, visit the Polyethylenimine Linear (PEI, MW 40,000) product page.